• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[The role of apolipoproteins A-I and A-II in plasma HDL remodeling].

作者信息

Wróblewska Małgorzata

机构信息

Department of Laboratory Medicine, Medical University of Gdańsk, 7 Debinki St., 80-211 Gdańsk, Poland.

出版信息

Postepy Biochem. 2009;55(3):315-22.

PMID:19928588
Abstract

Apolipoprotein (apo) A-I is a key HDL protein participating in the process of reverse cholesterol transport. A small part of plasma apo A-I exists as free protein which is a substrate for generation of discoid HDL precursors, containing small amounts of phospholipids and free cholesterol. The cycling of apo A-I between precursor and mature forms of HDL is an essential element of HDL remodeling in plasma. The second most abundant protein of human HDL is apo A-II, nevertheless, it is present only in about half of the HDL particles in plasma. The mechanism mediating the formation of HDL containing apo A-I and apo A-II is unknown. The role of apo A-II in reverse cholesterol transport generates controversy. Different observations indicate either proatherogenic or proinflammatory properties of apo A-II. Also the participation of apo A-II in plasma HDL remodeling remains unclear. Apo A-II maybe a factor stabilizing HDL particles. This protein may also take part in regulation of VLDL metabolism. The review presents current knowledge concerning participation of apo A-I and apo A-II in plasma HDL remodeling.

摘要

相似文献

1
[The role of apolipoproteins A-I and A-II in plasma HDL remodeling].
Postepy Biochem. 2009;55(3):315-22.
2
Speciation of human plasma high-density lipoprotein (HDL): HDL stability and apolipoprotein A-I partitioning.人血浆高密度脂蛋白(HDL)的物种形成:HDL稳定性和载脂蛋白A-I分配
Biochemistry. 2007 Jun 26;46(25):7449-59. doi: 10.1021/bi700496w. Epub 2007 May 27.
3
Rosuvastatin selectively stimulates apolipoprotein A-I but not apolipoprotein A-II synthesis in Hep G2 cells.瑞舒伐他汀选择性刺激Hep G2细胞中载脂蛋白A-I的合成,但不刺激载脂蛋白A-II的合成。
Metabolism. 2008 Jul;57(7):973-9. doi: 10.1016/j.metabol.2008.02.014.
4
Mechanism of action of niacin.烟酸的作用机制。
Am J Cardiol. 2008 Apr 17;101(8A):20B-26B. doi: 10.1016/j.amjcard.2008.02.029.
5
Different VLDL apo B, and HDL apo AI and apo AII metabolism in two heterozygous carriers of unrelated mutations in the lipoprotein lipase gene.脂蛋白脂肪酶基因两个不相关突变杂合携带者中极低密度脂蛋白载脂蛋白B、高密度脂蛋白载脂蛋白AI和载脂蛋白AII的不同代谢情况。
Clin Chim Acta. 2006 Jun;368(1-2):149-54. doi: 10.1016/j.cca.2005.12.038. Epub 2006 Feb 17.
6
Apolipoprotein A-I complexed with phospholipid promotes hepatic lipoprotein and apolipoprotein secretion in the perfused hamster liver.与磷脂复合的载脂蛋白A-I可促进灌注的仓鼠肝脏中脂蛋白和载脂蛋白的分泌。
J Investig Med. 1998 Dec;46(9):460-9.
7
Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.人载脂蛋白A-II的富集使对氧磷酶从高密度脂蛋白中被取代并损害其抗氧化特性:一种连接高密度脂蛋白蛋白质组成与抗动脉粥样硬化潜力的新机制。
Circ Res. 2004 Oct 15;95(8):789-97. doi: 10.1161/01.RES.0000146031.94850.5f. Epub 2004 Sep 23.
8
Non-enzymatic glycosylation of apolipoprotein A-I and its functional consequences.载脂蛋白A-I的非酶糖基化及其功能后果。
Diabete Metab. 1995 Apr;21(2):95-8.
9
Molecular processing of HDL by the liver during reverse cholesterol transport.
Z Gastroenterol. 1996 Jun;34 Suppl 3:147-8.
10
Apolipoprotein A-II, HDL metabolism and atherosclerosis.载脂蛋白A-II、高密度脂蛋白代谢与动脉粥样硬化
Atherosclerosis. 2002 Sep;164(1):1-13. doi: 10.1016/s0021-9150(01)00751-1.